Terauchi Y, Fujiwara H, Kurihara Y, Suganami H, Tamura M, Senda M, et al
Recent studies show patients taking semaglutide and other semaglutide drugs have more than a fourfold higher risk of developing NAION compared to those not taking GLP-1 medications, and the World Health Organization issued warnings in June 2025 about this serious complication
Designed for healthcare professionals, Ferumoxytol provides rapid and effective treatment of iron deficiency anemia (IDA), particularly in adult patients with chronic kidney disease (CKD) or when oral iron therapy is ineffective or not tolerated
After 4-6 weeks of confirmed tolerance, additional products can be introduced gradually
y l s minh bch m ng Bo cc k trn trng
Some trial participants in earlier research even said they stopped taking retatrutide because they felt they were losing too much weight